Carcinotech
2 known investors
Carcinotech develops 3D bioprinted tumour models using established cancer cell lines and fresh patient-derived tissue, offering assay-ready formats for drug testing, precision medicine, and preclinical oncology research. It also provides scientific services such as assay design and execution for researchers evaluating cancer therapeutics.
BiotechDeep TechHealthtech
Investors · 2
Frequently asked questions
- What does Carcinotech do?
- Carcinotech develops 3D bioprinted tumour models using established cancer cell lines and fresh patient-derived tissue, offering assay-ready formats for drug testing, precision medicine, and preclinical oncology research. It also provides scientific services such as assay design and execution for researchers evaluating cancer therapeutics.
- Who are Carcinotech's investors?
- Carcinotech's investors include Alba Equity, TRICAPITAL.